Hamel Associates’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDQ
Hamel Associates's IBDQ Position: Q4 2025 in Review
Hamel Associates sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 216,638 shares — an estimated $5.46M sold.
Hamel Associates first reported a position in IBDQ in Q3 2022 and held it in 13 quarters. The position peaked at $7.54M in Q4 2024. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.
- Hamel Associates reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
- Hamel Associates sold 216,638 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $5.46M.
- Hamel Associates first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2022 and held it in 13 quarters.
- Hamel Associates's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $7.54M in Q4 2024.
- 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.
Based on Hamel Associates's 13F filing for Q4 2025, filed 11 Feb 2026.